SARS-CoV-2 and Androgenic Alopecia: Exploring Links

    January 2021 in “ International Journal of Dermatology ”
    Mir Ibrahim Sajid, Dur-E Najaf, Ayesha Tariq Niaz, Samira Shabbir Balouch, Sajid Abaidullah
    Image of study
    TLDR Possible link between COVID-19 and hair loss; more research needed.
    Several articles explore the potential links between SARS-CoV-2 and androgenic alopecia (AA), a type of hair loss. Studies suggest that androgen receptor activity may play a role in the transcription and regulation of ACE-2 and TMPRSS2, potentially contributing to the development of androgenic alopecia in COVID-19 patients. The prevalence of AA was found to be higher in female patients aged over 69 years who were diagnosed with SARS-CoV-2. Clinicians and dermatologists should counsel their patients and raise awareness to decrease the mental burden in an already stress-prevalent time. Further research is needed to fully understand the potential link between androgenic alopecia and COVID-19.
    Discuss this study in the Community →

    Research cited in this study

    7 / 7 results

    Related Community Posts Join

    6 / 1000+ results

      community Trestolone (MENT) as a nuclear treatment

      in Treatment  99 upvotes 2 years ago
      Experimenting with trestolone as a treatment for hair loss in an attempt to avoid DHT-related treatments such as finasteride and dutasteride, and discussing the potential effects of its receptor selectivity on the androgen receptors in the scalp.

      community To all the young non-responders out there

      in Update  122 upvotes 2 years ago
      A 21 year old who has been taking various treatments for hair loss such as dutasteride, RU58841, minoxidil and finasteride with no results. Other users share their experiences of dealing with hair loss at an early age and offer advice on how to cope.

      community 1 month Pyrilutamide. A non responders story to everything.

      in Research/Science  218 upvotes 2 years ago
      My hairline, I am only 23. This conversation is about a user's experience with treatments for androgenic alopecia, including finasteride, dutasteride, RU, minoxidil, progesterone, melatonin, LLLT, oral minoxidil, and Pyrilutamide. They have tried many treatments over the course of two years without seeing much success, and they are considering getting a hair system as a last resort.

      community Binding affinity of pyrilutamide!

      in Update  169 upvotes 2 years ago
      Pyrilutamide, a nonsteroidal antiandrogen drug under development for the potential treatment of androgenic alopecia. The conversation discusses its binding affinity to the androgen receptor and the timeline for possible availability after trials are completed in the United States and China.

    Similar Research

    6 / 1000+ results